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Abstract.  Previous studies have demonstrated that 
interleukin-1  (IL-I) stimulates fibroblast growth 
(Schmidt,  J.  A.,  S. B.  Mizel,  D.  Cohn,  and I.  Green. 
1982. J.  Immunol.  128:2177-2182)  and binds to 
specific, high affinity receptors of BALB/c3T3 cells 
(Bird,  T. A., and J.  Saklatval.  1986. Nature (Lond.). 
324:263-265,  266-268).  We have investigated the 
mechanism of fibroblast growth stimulation by IL-1. 
Addition of fibroblast growth factor derived from 
platelets (PDGF) to a quiescent culture of BALB/c3T3 
cells produced 8-10-fold increase in DNA synthesis 
during 24-h incubation.  The cellular action of PDGF 
was mediated through competence induction and re- 
quired synergistic action of plasma-derived factors for 
full mitogenic activity. When tested at a  wide range of 
concentrations (0.1-100 pM), natural  IL-1 or recom- 
binant IL-1 produced only a maximum of 5-10%  of 
DNA synthesis elicited in response to PDGF or se- 
rum.  Induction of DNA synthesis required continuous 
presence of IL-1 and did not exhibit synergism with 
plasma.  Competence induction and mitogenic stimula- 
tion by PDGF was associated with early induction of 
proteins P32, P38, P46-48, P75, and changes in 
cytoskeletal organization.  Examination  of these early 
cellular changes showed that IL-1  did not produce 
similar induction of cellular proteins and the morpho- 
logical changes associated with growth stimulation. 
These results suggest that the mode of IL-1 action on 
BALB/c3T3 was not through competence induction. 
When IL-1  was added to cells rendered competent by 
brief exposure to PDGE  10-15 % additional DNA syn- 
thesis occurred during the first 24 h.  Extended incuba- 
tion of PDGF-treated cells in the presence of IL-1  re- 
vealed that the stimulation by IL-1  occurred 
predominantly  during  the subsequent cycle of DNA 
replication,  wherein DNA synthesis reached three- to 
fivefold higher than the untreated cultures.  We con- 
clude (a) IL-1 alone is not a potent mitogen for 
BALB/c3T3 cells, and does not bring cells out of the 
growth arrest Go phase,  (b) treatment with PDGF 
renders the cells more responsive to IL-1,  (c) part of 
the IL-1 action on competent cells may be character- 
ized as progression inducing activity, further,  (d) our 
results indicate that action of IL-1 on PDGF-treated 
cells produces sustained DNA synthesis for an ex- 
tended period, perhaps by preventing the entry of cells 
into growth arrest Go phase. 
I 
NTERLEUKIN-I (IL-I) I is known to induce a wide range 
of biological activities in numerous cell types (21, 23, 
31). In connective tissue cells, IL-1 has been shown to 
stimulate prostaglandin  production (15), collagenase produc- 
tion (15, 28), and proliferation  of human dermal fibroblasts 
(29) and BALB/c3T3 cells (12). Recent studies have demon- 
strated occurrence of high affinity IL-1 receptors on a variety 
of cell  types, including  human  lung  and BALB/3T3 fibro- 
blasts (6, 12, 14). Interestingly, the number of IL-1 receptors 
expressed by fibroblasts  is relatively high as compared with 
lymphoid cells (6,  9,  13,  14). Although,  full  biochemical 
and biological characterization  of IL-1 receptor is yet to be 
achieved,  the molecular size  of the IL-1 receptor appears 
1. Abbreviations  used in this paper:  EGF, epidermal growth factor;  FGF, 
fibroblast growth factor; IL-I, interleukin-1; PDGF, platelet-derived  growth 
factor. 
much  smaller  (82  kD)  than  the  other  well  characterized 
growth factors, e.g., platelet derived growth factor (PDGF), 
fibroblast growth factor (FGF), or epidermal growth factor 
(EGF), whose receptors are 160,000 D or greater (10, 17, 18, 
22).  It  is,  therefore,  of  great  interest  to  know  which 
receptor-mediated  signal transduction  mechanisms  and the 
early cellular  events induced  by IL-1 are common to those 
triggered by other growth factors of BALB/c3T3 cells.  Such 
studies  may further advance  our understanding  of the key 
steps involved in the regulation of  cell proliferation.  Previous 
studies  have demonstrated  that  specific growth factors  are 
functional  during  defined  stages  of cell cycle and induce 
specific biochemical events of the pathway(s) leading to the 
traverse  of quiescent cells from growth arrest Go to DNA 
replicative  S phase. Accordingly, initiation  of DNA synthe- 
sis and proliferative  response are brought about by a syner- 
gistic action of two types of polypeptides growth factors. One 
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of competence (competence factors), whereby treated cells 
come out of the growth arrest Go phase and enter the DNA 
synthesis phase when supplied with the second set of factors 
known as progression factors (EGF, insulin-like growth fac- 
tor, plasma) (25,  26, 32). How IL-1 induces fibroblast pro- 
liferation is not known.  The present study has revealed a 
novel action of IL-1 on fibroblast. It is shown here that unlike 
PDGF or FGF, IL-1 does not stimulate growth arrested cells 
to become competent or enter DNA synthesis phase. Instead, 
IL-1 acts on competent or exponentially growing cells where 
it induces their traverse from Go/Gj  into S phase and sus- 
tains growth by preventing entry of cells in growth arrest Go 
phase. 
Materials and Methods 
Cell Culture 
Stock culture of BALB/c3T3  cells was maintained as previously described 
(25). Growth medium was DME containing 10% FBS, L-glutamine (2 mM), 
penicillin (100 U/ml), and streptomycin (100 I.tg/ml). Assay medium was 
DME containing indicated concentration of platelet poor plasma,  L-glu- 
tamine  (2  mM),  penicillin  (100 U/ml),  streptomycin (100 ug/ml),  and 
[3H]thymidine  (5  pCi/ml). 
/L4 
Natural human IL-1 was purified from lipopolysaccharide stimulated pe- 
ripheral blood leukocyte conditioned medium by sequential chromatogra- 
phy on hydroxylapatite, TSK-3000,  and SP-TSK columns (11). Greater than 
90 % of the IL-1 activity in this preparation was due to IL-113. Recombinant 
IL-1 ct was from Genzyme Corp., Boston, MA. Recombinant IL-113 was pre- 
pared at the Upjohn Company or purchased from Genzyme Corp. FGF was 
from Collaborative Research, Inc., Bedford, MA. 
PDGF 
Human PDGF was purified by modification of previously described method 
(4, 30). Platelet extract fractionated on CM-Biogel was further purified on 
molecular sizing TSK-3000  and  cation exchange SP-TSK  column using 
HPLC. The specific activity of purified PDGF was 0.5  x  106 U/mg pro- 
tein. A unit of PDGF is defined as the amount that induces 50% of maxi- 
mum DNA synthesis. 
Platelet Poor Plasma 
Human platelet poor plasma and plasma from hypophysectomized  rats were 
prepared as before (25). 
Competence and Progression Assays 
BALB/c3T3  cells were cultured in 0.2 ml of growth medium at a density 
of 4  x  103 cells per well of a  96-well microtiter plate.  Plates were in- 
cubated at 37~  under 5% CO2, 95% air, and used for assay after 5 d. For 
competence assay,  cells were washed in DME and medium was replaced 
with assay medium containing 1-2 % human platelet poor plasma, and ap- 
propriate growth factor. Plates were incubated for 24 h as before. At the end 
of incubation, cells were fixed in methanol. The microwells were detached 
from the plates and radioactive thymidine incorporation was determined by 
scintillation counting using a Beckman counter (model No. LS3801; Beckman 
Instruments, Inc., Palo Alto, CA). For progression assay,  cells were first 
treated with 1-2 U PDGF for 4 h, washed, and either transferred to assay 
medium containing low concentration (0.5 %) of human platelet poor plasma 
or 2% hypophysectomized rat plasma and various concentrations of IL-1. 
[3H]Thymidine  was added at the start for a 24-h assay and after 24 h for 
a 48-h assay. 
Two-dimensional  Gel Electrophoresis 
Two-dimensional gel electrophoresis of proteins was performed by a mod- 
ification of the methods described by Anderson and Anderson (2, 3). First- 
dimension tube gels were run using pH 3.5 to 10.0 ampholytes. The second 
dimension, SDS-PAGE was performed using 10-20% gradient gels (1). 
Results 
Fig.  1 shows the effects of two classes of growth regulators 
on DNA synthesis in BALB/c3T3 cells. Addition of compe- 
tence factor PDGF to a quiescent culture of BALB/c3T3 cells 
produced a dose-dependent increase in DNA synthesis as de- 
termined in a 24-h competence assay. Growth stimulation by 
PDGF was  synergistically enhanced by plasma.  In the ab- 
sence or low concentration of plasma (0.1%,  in Fig.  1),  120 
pM PDGF was  required to achieve one-half of maximum 
DNA synthesis. Increasing the plasma concentration to 1% 
produced greater than two-fold enhancement of PDGF activ- 
ity (50 pM  PDGF was  needed to produce half-maximum 
DNA synthesis). Higher concentrations of plasma were even 
more effective; however, the background radioactivity was 
also increased.  To keep the background radioactivity low, 
most of our experiments used  1-2 % plasma.  It should be 
noted that the data in Fig.  1 are plotted after subtraction of 
background for each plasma concentration and the [3H]thy- 
midine uptake shown here represents stimulation by growth 
factors.  These  results  are  consistent  with  previously de- 
scribed mode of BALB/c3T3 cell proliferation in response to 
growth factors (25, 26, 32). Fig. "1 and at an expanded scale 
in the inset of Fig.  1 show stimulation of DNA synthesis in 
BALB/3T3 cells in response to recombinant IL-113. Similar 
results were obtained with IL-lct or IL-1 purified from lipo- 
polysaccharide stimulated PBL-conditioned medium. IL-1 at 
concentrations between 0.2 and 2 pM produced a slight in- 
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Figure 1. Induction of DNA synthesis in BALB/c3T3 fibroblasts by 
human IL-1 or PDGE BALB/c3T3 cells were plated in 96-well mi- 
crotiter plates and allowed to become confluent in DME containing 
10% FBS. 5 d after plating, spent medium was replaced with DME 
containing appropriate concentration of platelet poor plasma, in- 
dicated amounts of PDGF, or IL-1, and  1 pCi [3H]thymidine (sp 
act 78 IxCi/mmol). Results of [3H]thymidine incorporation in re- 
sponse to PDGF in 1 (m) or 0.1% (t3) platelet poor plasma, IL-1 in 
1 (*) or 0.1% (o) platelet poor plasma are plotted after subtraction 
of background radioactivity for each plasma concentration.  For 
clarity of depiction DNA synthesis in response to IL-1 is plotted at 
a 10-fold expanded scale in inset. 
The Journal of Cell Biology,  Volume 106, 1988  814 Figure 2. Two-dimensional gel electrophoresis of PDGF, IL-I, or platelet poor plasma-treated control cells. BALB/c3T3 cells were grown 
to confluence in 35-mm dishes and then transferred to 2 ml DME containing 1% plasma (A), and 250 pM PDGF (B), or 10 pM IL-1 (C) 
for 2 h before a 30-min pulse with 50 IxCi [35S]methionine. Cultures  were washed and cells were lysed in a  1% solution of NP-40 in 
reticulocyte saline buffer (0.01 M NaCI/0.01 M Tris-HC1/1.5 mM MgC12 pH 7.4) and supernatants were subjected to first dimension elec- 
trophoresis between pH 3.5 and 10 and second dimension using 10-20% gradient polyacrylamide gels. Autoradiographs from a representa- 
tive experiment  are shown here.  Proteins consistently induced two- to fourfold and quantified in Table I are marked by arrows. 
crease in DNA synthesis by fibroblasts. However, the thymi- 
dine incorporation in response to optimum concentration of 
IL-1 was only 5-10% of that produced by PDGF or serum. 
In various experiments performed with different batches of 
cells or different preparations of IL-1, the maximum thymi- 
dine incorporation in IL-l-treated cultures was 8,000-12,000 
cpm or less (3,000-6,000 cpm) if the growth of cells was fur- 
ther  arrested  by  incubation  in  the  growth  factor-depleted 
medium for 6-d instead of 5-d cells routinely used for the 
assay. In PDGF-treated cultures the maximum radioactivity 
incorporated  in  DNA  was  150,000-200,000  cpm.  Unlike 
PDGF, IL-1 activity was not dependent on the concentration 
of platelet-poor plasma  in  the  medium.  Fig.  1  shows  the 
[3H]thymidine incorporation in response to IL-1 in the pres- 
ence of 0.1  and  1%  platelet poor plasma.  In other experi- 
ments,  not  shown  here,  varying the  plasma concentration 
between 0.1 and 3 % did not significantly change the IL-1 re- 
sponse. The extent of stimulation of DNA synthesis by IL-1 
found here was contrary to the previous suggestions that IL-1 
is a growth factor for fibroblasts. Lack of induction of DNA 
synthesis by IL-1 under our experimental conditions was not 
due to the inactivation of IL-1 by human plasma. IL-1 diluted 
in human platelet poor plasma was equally active in thymo- 
cyte assay. Lack of growth stimulation was also not due to 
inhibition by prostaglandin produced in response to IL-1 or 
any nonspecific inhibition by IL-1 preparation, because IL- 
I-treated cells were fully responsive to other mitogens of 
BALB/c3T3 cells (see below, Fig. 4).  These results suggest 
that IL-1  does not  stimulate DNA  synthesis in  growth-ar- 
rested  cultures.  A  5-10%  increase  in  DNA  synthesis  ob- 
served in the presence of IL-1 is perhaps due to its action on 
a  small  population  of nonsynchronized  cells  still  cycling. 
These  experiments  suggested  that  the  mode  of fibroblast 
growth  stimulation  by  IL-1  (as  reported  before),  may be 
different  from  the  previously  described  fibroblast growth 
factors e.g.,  PDGF or FGE 
Further  evidence  that  IL-l-mediated  proliferative  re- 
sponse was different from the other growth factors is derived 
from  examination  of early  biochemical  events  associated 
with the action of PDGF or FGE Fig. 2 shows that treatment 
of density-inhibited BALB/c3T3  cells with PDGF  induced 
increased  expression  of  specific  cellular  proteins  within 
1-2 h, as determined by [35S]methionine  labeling of cellular 
proteins. A relative fold induction of specific proteins corre- 
sponding to M, 32,000,  38,000,  46,000,  48,000,  and 75,000 
was determined by scanning the autoradiograms.  The rela- 
tive integrated intensity of the protein of interest in each gel 
was compared with a  reference protein (protein exhibiting 
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Optical  density 
Molecular  Platelet  poor 
Protein  mass  pl  plasma  PDGF  IL-1 
x  16  ~3 
P32  32  6.8  0.80  3.64  1.48 
P38  38  7.3  1.40  3.24  1.86 
P46  46  6.7  0.49  2.18  0.50 
P48  48  7.0  0.29  1.21  0.38 
P75  75  5.2  1.55  3.82  2.28 
Individual  proteins in autoradiographs were first  identified  visually and then 
quantified  by computer aided densitometry using a Visage image analysis sys- 
tem (Biolmage Corp.,  Ann Arbor, MI).  Optical  densities (in arbitrary units) 
were determined by dividing the integrated intensity of each protein shown by 
the integrated intensity of a reference protein that exhibited none or smallest 
change in response to growth factor treatment. Data presented here are average 
of two separate experiments. 
tuitary hormone.  We  have  used  somatomedin C-deficient 
plasma from hypophysectomized  rats or low concentration of 
human plasma to determine whether the induction of DNA 
synthesis in BALB/c3T3 cells by IL-1  was due to its action 
as a progression factor. In Fig. 4 A, cultures of BALB/c3T3 
cells were rendered competent by brief exposure (4 h) to hu- 
man platelet-derived growth factor at a concentration of 1-2 
U/ml.  As indicated by the open bar in Fig. 4 A,  PDGF in 
the  presence  of optimum  concentration  of human  plate- 
let-poor plasma  produced about  sixfold increase in  DNA 
synthesis  (124,200  +  1,400  cpm  above  background).  In 
progression factor-deficient hypophysectomized rat plasma 
or low concentration of human platelet-poor plasma, a 4-h 
exposure to PDGF produced '~30-40% (41,700 +  150 cpm) 
of this maximum DNA synthesis. Addition of IL-1 to PDGF- 
none or smallest change) and expressed in arbitrary units. 
Table I shows that treatment with PDGF produced four- to 
fivefold induction of P32, P46, P48, and two- to threefold in- 
crease in the synthesis of P38 and P75.  Similar increase in 
synthesis of 29- and 35-kD proteins was reported by Pledger 
et al. (33). The 29-kD protein corresponds to our P32. Al- 
though our results show a 2-3-kD higher molecular mass for 
this protein, more recent experiments from the laboratory of 
the investigators confirms this  result (Pledger, W.  J.,  per- 
sonal  communication).  Similarly,  the  35-kD  protein may 
correspond to our P38. In this study we also found that the 
46- and 48-kD proteins,  expressed at a  very low level in 
growth-arrested cells, are stimulated severalfold upon PDGF 
treatment. IL-1, tested at several concentrations, did not pro- 
duce significant change in the expression of P38,  P46,  and 
P48, and only a slight increase in P32. At higher concentra- 
tions (20 pM), IL-1 may have actually inhibited the expres- 
sion of these proteins (unpublished observations). 
It is known that cell shape changes are important deter- 
minants in the regulation of cell growth, migration and dif- 
ferentiation. DNA synthesis and mitosis in fibroblast treated 
with PDGF are preceded by changes  in actomyosin c3,to- 
skeletal system, resulting  in changes  in cell shape.  Fig.  3 
shows  the effect of PDGF on morphology of BALB/c3T3 
cells. After reaching a near confluent density, cells in control 
cultures  remained  uniformly hexagonally or  pentagonally 
shaped with flattened morphology, covering much of the dish 
surface. PDGF treatment produced a striking change in mor- 
phology and  cell  shape  characterized by  cell  elongation. 
Induction of cell stretching was a function of PDGF concen- 
tration and enhanced by plasma. IL-1 tested at several con- 
centrations (0.1-10 pM) or extraphysiological concentration 
(100 pM) did not produce any visible change in morphology 
of these cells.  Taken together,  the DNA  synthesis experi- 
ments  and  the  examination  of other  cellular changes  as- 
sociated with growth factor-induced cell proliferation, we 
conclude that IL-1  alone is  not a  potent mitogen or com- 
petence-inducing factor for fibroblasts. 
The  second  set  of factors  required  for  the  traverse  of 
BALB/c3T3 cells from Go/Gt  to S  phase of cell cycle are 
present in plasma  (progression factors). Much of the pro- 
gression activity of human plasma is due to somatomedin C, 
the plasma concentration of which is under the control of pi- 
Figure 3. Morphological changes associated with mitogenic stimu- 
lation of BALB/c3T3 cells with PDGE Cells were grown to con- 
fluence and then transferred to 1% plasma (A) and treated with 250 
pM PDGF (B) or 10 pM IL-1 (C). After 24 h, cells were fixed in 
methanol and photographed. 
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Figure 4.  Stimulation of DNA synthesis in PDGF- 
treated cells by IL-1. Density arrested BALB/c3T3 
cells in 96 well microliter plates were washed once 
with DME and then treated with PDGF (1 U/ml) for 
4 h. Control cultures received PBS instead of PDGF. 
After 4 h cells were washed and transferred to culture 
medium containing 0.5 % platelet poor plasma as fol- 
lows: control cultures + 2 pM IL-1 (~); PDGF-treat- 
ed cultures (~); PDGF-treated cultures + 2 pM IL-1 
(m). The open bar (t2) shows [3H]thymidine  incorpo- 
ration in cultures optimally stimulated with PDGF 
and 2% platelet poor plasma. The later also indicates 
that the cells were fully capable of undergoing DNA 
synthesis when  supplied with  optimum concentra- 
tions of PDGF and plasma factors. In A, [3H]thymi- 
dine was added at the start of the incubation after 
PDGF pulse and DNA synthesis determined during 
the first 24 h. In B, [3H]thymidine was added after 
24 h and DNA synthesis determined during 24-48 h 
interval.  The data  are  plotted  after  subtraction of 
background counts obtained in the absence of treat- 
ment as SD of mean, n  =  3. 
treated competent cells produced a slightly higher level of 
DNA synthesis. As shown in Fig. 4 A, this increase in DNA 
synthesis during the first 24 h was ",,2-5 % more than the ad- 
ditive effects of PDGF and IL-1. These results suggest that 
IL-1 may enhance DNA synthesis in competent cells but un- 
like insulin-like growth factor or FGF it does not fully re- 
store the progression activity of plasma. When the cells first 
treated with PDGF for 4 h, and then incubated with IL-1 and 
DNA synthesis determined during 24-48-h interval, IL-l-in- 
duced DNA synthesis was greatly enhanced. Fig. 4 B shows 
the DNA synthesis in response to optimum concentration of 
IL-1  in the presence or absence of PDGF pretreatment. In 
the  cultures  receiving IL-1  alone,  DNA  synthesis  during 
24-48-h interval did not change significantly, as compared 
with 0-24-h interval. DNA synthesis in cultures that were 
pulsed with PDGF declined to ",,50% of the initial stimula- 
tion (from ~41,700 +  150 cpm during 0-24 h to 22,500 + 
280 cpm). During the same interval, DNA synthesis in PDGF- 
treated cultures receiving IL-1 was 166% higher than the ad- 
Table II. IL-l-mediated DNA Synthesis in BALB/c3T3 
Fibroblasts 
Labeled nuclei/field 
Treatment  0-24 h  24-48 h 
Platelet poor  plasma  17,5  -I- 2.0  11,0  +  1.0 
IL-1  17.0  _  1,1  7,0  5:1,0 
PDGF  63.2  _  7.2  17.0  _4:.. 1.0 
PDGF  +  IL-1  66,5  +  5.8  41.5  +  2,0 
BALB/c3T3  cells were plated as described previously in  legend to Fig,  1. 
Spent medium from the confluent cultures was replaced with DME containing 
0.5% platelet poor plasma and 2 pM recombinant IL-I 13 or 1 U/ml PDGF or 
both PDGF and IL-1.  Cells were pulsed with [3H]thymidine during 0-24 or 
24-48 h  interval. At the end of the incubation, cells were fixed in methanol. 
Autoradiography was performed as described before (4), Labeled nuclei were 
counted under  10x  magnification, Each treatment was performed  in tripli- 
cates.  Data indicates the standard error of mean. 
ditive effect of PDGF and IL-1. Further, during the 24-48-h 
interval, the IL-l-mediated DNA synthesis in PDGF-treated 
cells was •ll-fold  higher than cells treated with IL-1 alone. 
A  similar  pattern  of stimulation  of DNA  synthesis  by 
PDGF and IL-1 was revealed when the activities were deter- 
mined by assessing the labeled nuclei after autoradiography. 
As shown in Table II, suboptimum concentration of PDGF 
(1 U/ml) produced about four- to fivefold increase in number 
of labeled cells in a confluent culture. Addition of IL-1 did 
not significantly change the number of labeled nuclei during 
the first 24 h. However, during the 24-48-h [3H]thymidine 
pulse, the number of labeled nuclei in cultures treated with 
PDGF  and  IL-1  together was  about  fourfold higher than 
PDGF alone (calculated after the subtraction of background 
labeling  in  the  presence of platelet poor plasma).  These 
results also show that only "-,17% of the cells that were ini- 
tially (0-24 h)  stimulated by PDGF,  actively synthesized 
DNA during the 24-48-h interval; whereas,  ,'~64%  of the 
cells actively synthesized DNA in cultures treated with both 
PDGF and IL-1 during the same interval. One interpretation 
of this sustained DNA synthesis may be that the action of IL- 
1 allowed reentry into S phase of cells that were initially 
stimulated with PDGE  In the absence of IL-1  these cells 
would have entered Go phase and become growth arrested. 
IL-1  was  an extremely potent mediator of augmentation of 
DNA synthesis in PDGF-treated cells. Maximum effects on 
BALB/c3T3 were produced with as low as 2 pM IL-1. These 
levels of IL-1 were 5-10-fold lower than required for stimula- 
tion of mouse thymocytes. 
We also examined whether the observed effects of IL-1 on 
DNA synthesis in confluent cultures are reflected in the ac- 
tual increase in cell number in sparse cultures. In the experi- 
ment shown in Fig. 5, cell proliferation over a 4-d period was 
determined in the presence of suboptimum concentration of 
PDGF (1 U/ml), 2 pM IL-I, or PDGF and IL-1 together. The 
change in cell number over the control cultures (2 % platelet 
poor plasma) are shown here. Clearly, addition of IL-1 to the 
PDGF-containing cultures resulted in higher cell growth. 
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Figure 5.  Proliferation of BALB/c3T3 fibroblasts in response to 
PDGF and IL-1. Stock cultures were trypsinized and cells were 
plated in 12 well culture plates, and 2 ml DME containing 2 mM 
glutamine, penicillin (100 U/ml), streptomycin (100 pg/ml), and 2 % 
platelet poor plasma. After 24 h, medium and floating cells were 
removed and replaced with the above fresh medium containing 
either 2 pM IL-I  (t~), or suboptimal concentration (1  U/ml) of 
PDGF (~), or PDGF and IL-1 together (g). Plates were incubated 
at 37~  in 5% Co2, 95% air. At the end of incubation, cultures 
were trypsinized and counted using a Coulter counter (model ZM; 
Hialeah, FL). The data indicate increase in cell number after 4 d, 
over the platelet poor plasma control culture (0.4 x  104 cells/dish). 
Discussion 
Conflicting reports have appeared on growth promoting ef- 
fects of IL-1 on mesenchymal cells (7,  11,  12, 27, 29,  33). 
Schmidt et al. (29) initially demonstrated that the fibroblast 
growth-stimulating activity of the mixed lymphocyte super- 
natant was biochemically identical to IL-1, and suggested that 
IL-1  may  function as  a  fibroblast growth  factor.  Similar 
proliferation of human dermal fibrobtasts in response to IL-1 
was subsequently reported by Kimball et al. (19). More re- 
cently Dower et al. (14) and Bird and Saklatvela (6) showed 
that BALB/c3T3 cells exhibit high affinity cell surface recep- 
tors for IL-1. Dower et al. (12) also showed a small enhance- 
ment of DNA synthesis in BALB/c3T3 cells by IL-1.  How- 
ever, other reports show that IL-1 alone was  ineffective in 
stimulation of growth of fibroblasts (7, 11, 27, 33) and smooth 
muscle cells (20). 
When the fibroblast-stimulating activity of IL-1 was exam- 
ined in an assay similar to that widely used for the determina- 
tion of PDGF or FGF, we found that IL-1 produced only a 
small change in DNA synthesis. Compared with the DNA 
synthesis induced by PDGF or serum, in most cases, IL-1 
stimulation was  '~5 %.  These results were contrary to the 
previous suggestion that IL-1  is a  growth factor for fibro- 
blasts. Detailed investigation of IL-1 activity on Go growth- 
arrested,  PDGF-treated competent cells  and  cycling cells 
have indicated a  novel action of IL-1  on fibroblasts.  It is 
demonstrated here that IL-1  alone does not release Go-ar- 
rested,  quiescent  fibroblasts to  enter  DNA  replicative  S 
phase. The DNA synthesis results are corroborated by stud- 
ies showing that IL-1 failed to induce specific cellular changes 
associated with mitogenic stimulation of BALB/c3T3 cells 
with PDGF. PDGF treatment of quiescent cultures of  BALB/ 
c3T3 cells produced a three- to fivefold increase in the ex- 
pression of several proteins. Expression of these proteins is 
coupled with  mitogenic stimulation of these cells.  Trans- 
formed variants of BALB/c3T3 cells, which do not require 
exogenous PDGF for growth, express the PDGF-inducible 
proteins constitutively (24). In this regard, our quantitation 
of PDGF-inducible proteins reveal that proteins P46 and P48, 
which are produced at a very low level in growth-arrested 
cells, are strongly induced by PDGE The induction of these 
proteins may have remained undetected in previous studies. 
Stimulation of BALB/c3T3 cells with PDGF or serum, oc- 
curs with a concomitant alteration in cytoskeletal organiza- 
tion resulting in cell shape changes. Changes in cell shape 
are important for cell growth (5, 8, 16). IL-1 added to growth- 
arrested cells neither produced a significant increase in the 
expression of the above cellular proteins nor the morphologi- 
cal changes. These results clearly showed that IL-I was not 
effective in  releasing the  cells  from the growth  arrest Go 
phase. 
We show that action of IL-1 is on competent and exponen- 
tially  growing  cells,  prestimulated  by  mitogens  such  as 
PDGE On competent cells, part of the DNA synthesis in re- 
sponse to IL-1 may be characterized as progression inducing 
activity, allowing the traverse of cells through Go/G~ into S 
phase. However, the IL-1 activity on BALB/c3T3 cells ap- 
pears different from the previously characterized progres- 
sion factor EGF or insulin-like growth factor (25,  26, 32). 
First, EGF alone stimulates DNA synthesis in BALB/c3T3 
cells, which is two- to threefold more than IL-1 alone (data 
not shown), although, EGF-stimulated DNA synthesis was 
only •30%  of that stimulated by PDGE Second, the syner- 
gism between PDGF and EGF can be observed in a 24-h 
competence/progression assay (25, 26, 32). As shown here 
(Fig. 4 and Table II), the stimulation of DNA synthesis by 
IL-1  occurred predominantly during  a  24-48-h  interval. 
Brief  exposure of  quiescent cells to a suboptimum concentra- 
tion of PDGF stimulated DNA  synthesis during  the first 
24 h. Unless PDGF treatment was repeated, DNA synthesis 
declines and cells become growth arrested. When IL-1 was 
present in the culture medium, DNA synthesis was main- 
tained about three- to fourfold greater than PDGF alone or 
ll-fold higher than IL-1 alone (Fig. 4 B). The enhanced DNA 
synthesis may result from reentry into S phase of cells emerg- 
ing  from the  first round of DNA  replication initiated by 
PDGE This may occur if IL-1 somehow prevents the entry 
of cells into growth arrest Go phase. These data also explain 
the IL-1 induced fibroblast growth stimulation reported by 
Schmidt et al. (29) and Kimball et al. (19). Their studies used 
serum (instead of plasma), which contained 1-2 ng PDGF 
and plated cells at low densities. Under these conditions a 
larger population of calls are expected to remain nonsyn- 
chronized, out of Go arrest. 
The data presented here demonstrate the role of  IL-1 in the 
regulation of fibroblast growth through a unique mechanism. 
These findings reveal an interesting system to study a very 
poorly understood phenomenon of Go growth arrest. These 
studies also suggest that a collective action of the two macro- 
phage derived monokines, IL-1 and a macrophage-derived 
growth factor may constitute a complete system for prolifera- 
The Journal of Cell Biology, Volume 106, t988  818 tive responses in wound healing,  inflammation,  and athero- 
sclerosis where large number of macrophages are found de- 
posited. 
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